ROCKVILLE, Md. (March 16, 2021) — When the severe winter storm struck Texas in February, the American Kidney Fund (AKF) mobilized its longstanding Disaster Relief Program to help patients in crisis, providing $325,000 to more than 1,600 dialysis and post-transplant patients who were facing critical needs. This support was made possible by generous donations from the public and from Alnylam Pharmaceuticals, Inc., Apellis Pharmaceuticals, Inc., Horizon Therapeutics plc, Otsuka America Pharmaceutical, Inc. and Vifor Pharma.
Water service disruptions, power outages and temporary dialysis clinic closures put patients in dangerous and challenging positions. Donations made it possible for AKF to support patients with emergency grants of $200 each that helped them find alternative shelter and pay for renal-friendly foods, as well as transportation and medical essentials.
"We thank our corporate partners for their generosity that has made emergency relief possible to so many low-income Texans facing challenging circumstances as a result of the storm," said LaVarne A. Burton, AKF president and CEO. "A disaster like the one that struck Texas is particularly difficult for people with kidney failure who are already struggling to make ends meet, and we are grateful to our supporters who enabled us to provide much-needed assistance."
AKF covered the cost of grant processing and check distribution to ensure that the maximum number of patients in need received desperately needed support. AKF is one of only three nonprofits in the nation to have received the top 4-Star rating from Charity Navigator for 19 consecutive years — every year the organization has been rating nonprofits — giving donors the confidence that their contributions will be used to maximum efficiency. Contributions can be made to help AKF be there for patients during disasters, and year-round, through programs of prevention, early detection, financial support, disease management and advocacy.
About the American Kidney Fund
The American Kidney Fund (AKF) fights kidney disease on all fronts as the nation’s leading kidney nonprofit. AKF works on behalf of the 37 million Americans living with kidney disease, and the millions more at risk, with an unmatched scope of programs that support people wherever they are in their fight against kidney disease—from prevention through transplant. With programs that address early detection, disease management, financial assistance, clinical research, innovation and advocacy, no kidney organization impacts more lives than AKF. One of the nation’s top-rated nonprofits, AKF invests 97 cents of every donated dollar in programs, earning the highest 4-Star rating from Charity Navigator for 20 years in a row as well as the Platinum Seal of Transparency from Candid, formerly GuideStar.